1. Home
  2. TENX vs JBDI Comparison

TENX vs JBDI Comparison

Compare TENX & JBDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • JBDI
  • Stock Information
  • Founded
  • TENX 1967
  • JBDI 1983
  • Country
  • TENX United States
  • JBDI Singapore
  • Employees
  • TENX N/A
  • JBDI N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • JBDI
  • Sector
  • TENX Health Care
  • JBDI
  • Exchange
  • TENX Nasdaq
  • JBDI Nasdaq
  • Market Cap
  • TENX 25.0M
  • JBDI 20.4M
  • IPO Year
  • TENX N/A
  • JBDI 2024
  • Fundamental
  • Price
  • TENX $5.99
  • JBDI $1.02
  • Analyst Decision
  • TENX Strong Buy
  • JBDI
  • Analyst Count
  • TENX 3
  • JBDI 0
  • Target Price
  • TENX $15.00
  • JBDI N/A
  • AVG Volume (30 Days)
  • TENX 15.7K
  • JBDI 21.3K
  • Earning Date
  • TENX 08-13-2025
  • JBDI 01-01-0001
  • Dividend Yield
  • TENX N/A
  • JBDI N/A
  • EPS Growth
  • TENX N/A
  • JBDI N/A
  • EPS
  • TENX N/A
  • JBDI N/A
  • Revenue
  • TENX N/A
  • JBDI $9,017,000.00
  • Revenue This Year
  • TENX N/A
  • JBDI N/A
  • Revenue Next Year
  • TENX N/A
  • JBDI N/A
  • P/E Ratio
  • TENX N/A
  • JBDI N/A
  • Revenue Growth
  • TENX N/A
  • JBDI N/A
  • 52 Week Low
  • TENX $3.25
  • JBDI $0.49
  • 52 Week High
  • TENX $7.89
  • JBDI $39.41
  • Technical
  • Relative Strength Index (RSI)
  • TENX 51.19
  • JBDI 51.86
  • Support Level
  • TENX $5.88
  • JBDI $0.99
  • Resistance Level
  • TENX $6.02
  • JBDI $1.09
  • Average True Range (ATR)
  • TENX 0.13
  • JBDI 0.05
  • MACD
  • TENX -0.01
  • JBDI 0.00
  • Stochastic Oscillator
  • TENX 70.37
  • JBDI 56.25

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About JBDI JBDI Holdings Limited Ordinary Shares

JBDI Holdings Ltd is a supplier of Reconditioned and new Containers in Singapore. Its products include Reconditioned and new steel drums, plastic drums, carboys and IBCs.

Share on Social Networks: